Nahon, P., Brugière, O., Marcellin, P. and Valla, D. (2004) Role protecteur accidentel de l’interféron alpha contre Mycobacterium tuberculosis au cours d’un traitement anti viral C. Gastroentérologie Clinique et Biologique, 28, 609-618.
http://dx.doi.org/10.1016/S0399-8320(04)95020-8

has been cited by the following article:

• TITLE: Reactivation of Tuberculosis during Dual Therapy with Pegylated Interferon and Ribavirin for Chronic Hepatitis C about a Case

  AUTHORS: D. Soro, S. Koné, A. Ouattara, A. W. Ndjitoyap, A. J. B. Okon, D. Diallo, C. Assi, K. E. Allah, M. J. Lohoues Kouacou, B. M. Camara

  KEYWORDS: Chronic Hepatitis C Virus, Tuberculosis, Treatment

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.5 No.7, July 15, 2015

  ABSTRACT: The infection by the virus of the hepatitis C can be associated with other infectious diseases, including the viral and bacterial infections of which the tuberculosis. The infection to Mycobacterium tuberculosis can remain latent during several years and show itself during a state of immunesuppression. The role of the antiviral treatment in the reactivation of the tuberculosis is debated. We bring back an observation of tubercular reactivation during dual therapy with pegylated interferon and ribavirin for a viral chronic hepatitis C. A virologique answer slow was obtained in the 40th week, as well as the reactivation of the tuberculosis. The tuberculosis was of ganglionic localization at our patient. The antituberculous treatment was established while maintaining the treatment. The evolution of the tuberculosis under treatment was favorable but for the VHC, we noted a virologique answer with premature relapse.